What Is a Normal Fasting Insulin Level in PCOS?

What Is a Normal Fasting Insulin Level in PCOS?

For most women with PCOS, a fasting insulin below 10 µIU/mL is considered optimal, with values between 10–25 µIU/mL representing a gray zone where insulin resistance is likely even if a standard lab flags nothing. The main caveat: labs print reference ranges built from mixed populations, so many women with PCOS are told their insulin is fine when it isn't. The exception is women on metformin or GLP-1 therapy — their numbers can look deceptively low without reflecting true metabolic improvement.

---

Why Standard Lab Ranges Miss PCOS Insulin Resistance

The reference range printed on most fasting insulin reports — typically 2–25 µIU/mL — was not derived from women with PCOS, and it was not designed to detect early insulin resistance. It was built to flag frank hyperinsulinemia associated with insulinoma or severe metabolic syndrome. That is a very different clinical question from the subtle, compensated hyperinsulinemia that characterizes PCOS.

In compensated insulin resistance, the pancreas secretes more insulin to keep blood glucose technically normal. A fasting glucose of 88 mg/dL can coexist with a fasting insulin of 18 µIU/mL — both values fall inside standard reference ranges, yet the HOMA-IR score (glucose × insulin ÷ 405) would be 3.9, well above the 2.0–2.5 threshold researchers use to define insulin resistance in reproductive-age women (Carmina & Lobo, Fertility and Sterility 2004; PMID: 14766371).

A systematic review of 35 studies found that HOMA-IR ≥ 2.5 correctly identified insulin resistance in PCOS with 73–84% sensitivity depending on population ethnicity and BMI category (Mannerås-Holm et al., Journal of Clinical Endocrinology & Metabolism 2011; PMID: 21123446). That means a meaningful proportion of women with true metabolic dysfunction receive a clean bill of health from a lab that only prints a reference range rather than a calculated ratio.

The practical implication: always ask for both fasting insulin and fasting glucose on the same blood draw so your HOMA-IR can be calculated. A fasting insulin under 7 µIU/mL with a HOMA-IR under 1.5 is considered metabolically optimal by most functional medicine practitioners. A fasting insulin between 7–10 µIU/mL warrants lifestyle attention. Anything above 10 µIU/mL — even if your lab marks it in-range — deserves a conversation with your provider, especially if you also have elevated fasting glucose or cycle irregularity.

---

Lab Tests for Insulin Resistance in PCOS: Beyond Fasting Insulin

Fasting insulin alone is a single snapshot. It can be artificially suppressed by stress-induced cortisol surges the morning of the blood draw, or elevated by a meal eaten less than 10 hours before the test. A more complete picture requires several complementary markers.

HOMA-IR is the most widely validated surrogate for insulin resistance in PCOS research. Calculate it as: (fasting insulin µIU/mL × fasting glucose mg/dL) ÷ 405. A value above 2.0 is the conventional threshold; above 2.5 is consistent across most PCOS studies as the cutoff for clinically significant resistance.

Fasting C-peptide measures pancreatic insulin secretion directly, independent of exogenous insulin or lab assay variability. In women on insulin-sensitizing medications, C-peptide can reveal whether the pancreas is still overcompensating even when peripheral insulin looks suppressed.

Two-hour insulin during an oral glucose tolerance test (OGTT) is the gold standard for diagnosing postprandial hyperinsulinemia. Many women with PCOS have normal fasting insulin but spike above 150 µIU/mL at the two-hour mark — a pattern associated with significantly higher androgen levels and anovulation rates (Legro et al., Journal of Clinical Endocrinology & Metabolism 1999; PMID: 10022416).

HbA1c and fasting glucose are diabetes screening tools but are relatively insensitive for early insulin resistance. An HbA1c of 5.3% and a fasting glucose of 90 mg/dL are both "normal" yet perfectly compatible with a HOMA-IR of 3.5.

Fasting triglycerides provide an indirect metabolic signal. Triglycerides above 100 mg/dL in a fasting, non-pregnant woman under 40 often reflect hepatic insulin resistance even before glucose dysregulation appears. A triglyceride-to-HDL ratio above 3.0 is a well-recognized proxy for insulin resistance in populations where direct insulin testing is unavailable (McLaughlin et al., American Journal of Cardiology 2005; PMID: 15882677).

If you've ever received a normal fasting insulin result but still felt metabolically off, the article on why fasting insulin can look normal while you feel awful explains exactly why that disconnect happens and what additional tests to request.

---

Insulin Resistance and Nutrient Deficiencies in PCOS

Chronic hyperinsulinemia doesn't just affect blood sugar — it systematically depletes several micronutrients and creates a self-reinforcing cycle that makes insulin resistance harder to resolve without addressing the nutritional gaps.

Magnesium is the most consistently documented deficiency in insulin-resistant PCOS. Magnesium acts as a cofactor for the insulin receptor tyrosine kinase — without adequate magnesium, the receptor cannot transduce the insulin signal properly regardless of how much insulin is present. A meta-analysis of 25 randomized controlled trials found that magnesium supplementation significantly reduced fasting insulin (weighted mean difference −1.1 µIU/mL), fasting glucose, and HOMA-IR in people with insulin resistance or type 2 diabetes (Simental-Mendía et al., European Journal of Clinical Nutrition 2016; PMID: 26404370). Women with PCOS show serum magnesium levels roughly 19% lower on average than age-matched controls, and the deficit correlates directly with HOMA-IR severity.

Zinc regulates insulin synthesis, storage, and secretion in pancreatic beta cells. It also inhibits the 5-alpha reductase enzyme, which converts androgens to their more potent dihydrotestosterone form — relevant because PCOS-associated hyperinsulinemia drives androgen excess, and zinc deficiency amplifies that pathway. Several trials have shown zinc supplementation (25–40 mg/day) reduces fasting insulin and testosterone in PCOS (Foroozanfard et al., Hormone and Metabolic Research 2015; PMID: 25356603). Understanding the normal zinc level in PCOS is an important complement to insulin testing because the two markers often move together.

Vitamin D modulates pancreatic beta-cell function through the vitamin D receptor expressed on insulin-secreting cells. A 12-week trial of vitamin D3 supplementation (50,000 IU weekly) in women with PCOS improved HOMA-IR by 23% and reduced fasting insulin significantly compared to placebo (Wehr et al., European Journal of Endocrinology 2011; PMID: 21288940). Vitamin D deficiency is present in 67–85% of women with PCOS depending on latitude and skin pigmentation, making it one of the highest-yield targets in any PCOS nutrient protocol.

Inositol — specifically the myo-inositol to D-chiro-inositol ratio — deserves mention because it functions as an intracellular insulin second messenger. Insulin resistance in PCOS appears partly mediated by a defect in inositol phosphoglycan signaling, and supplementation with a 40:1 myo- to D-chiro-inositol ratio has been shown to restore ovulation and reduce fasting insulin in multiple trials.

B-vitamins, particularly thiamine (B1), are consumed rapidly during glucose metabolism. Chronically elevated insulin drives glucose flux through metabolic pathways that deplete thiamine faster than a normal diet replaces it. If you are also experiencing neurological symptoms alongside insulin resistance — brain fog, peripheral tingling, fatigue that doesn't respond to sleep — it is worth reviewing the thiamine deficiency symptom checklist as part of a broader PCOS nutrient audit.

The table below summarizes the key deficiencies, their mechanisms in PCOS, and the evidence-backed repletion doses:

Omega-3 fatty acids interact with insulin resistance through multiple pathways — they reduce hepatic triglyceride synthesis, lower inflammatory cytokines that impair insulin signaling, and improve adiponectin levels. A deeper look at low omega-3 symptoms and optimal dosing is worthwhile for any woman with PCOS and elevated triglycerides on her labs.

---

The Psychological Dimension of Living with Unrecognized Insulin Resistance

Women with PCOS spend a median of 2–3 years seeking a diagnosis — a period often characterized by being told that lab values are "normal" while symptoms continue to accumulate. This diagnostic delay has measurable psychological consequences. Studies consistently report that women with PCOS have depression rates approximately twice that of the general population, and anxiety prevalence roughly 5 times higher (Blay et al., Human Reproduction Update 2021). These aren't simply reactions to cosmetic symptoms — they reflect the neurobiological effects of hyperinsulinemia itself.

Insulin resistance directly impairs brain glucose uptake in regions governing mood and executive function. The prefrontal cortex and hippocampus have high densities of insulin receptors, and when peripheral insulin resistance extends centrally, cognitive symptoms follow: difficulty concentrating, emotional dysregulation, the kind of pervasive fatigue that sleep doesn't fix. For many women, the psychological burden intensifies specifically because they can't point to a lab value that justifies how bad they feel. A fasting insulin of 18 µIU/mL doesn't trigger alarm in a standard primary care visit, yet it may be driving a cascade of symptoms that feel completely overwhelming.

If a secondary pathology is also present — such as an adrenal or ovarian tumor contributing to androgen excess — the diagnostic complexity compounds further. Tumors producing androgens or cortisol can dramatically worsen PCOS phenotype and make insulin resistance more severe and faster-progressing. Women in this situation often describe a sudden worsening of symptoms after a period of relative stability, a pattern that warrants imaging and expanded endocrine labs beyond fasting insulin alone. The psychological toll of that kind of medical complexity — being sick for 15 months or more before a structural cause is identified — is real and deserves acknowledgment in any honest clinical conversation about PCOS.

Understanding what fasting insulin tells you about your hormone balance can be validating for women who have felt dismissed by labs that look normal on paper.

---

What This Means for Your Formula

Personalized supplementation for PCOS-related insulin resistance should follow the lab results — not a generic women's health formula. The nutrients that move the needle most consistently are the ones that directly address the insulin receptor signaling deficit and the downstream depletions that hyperinsulinemia creates.

Magnesium Glycinate is the form Ones includes in its Magnesium Complex, providing elemental magnesium in a chelated form that avoids the gastrointestinal side effects of oxide or sulfate. The glycinate form also supports GABA-mediated calm, which matters because the HPA axis dysfunction common in PCOS — driven partly by insulin resistance — elevates nighttime cortisol and fragments sleep. Magnesium glycinate has been shown to reduce both HOMA-IR and sleep disturbance scores in metabolic trials, making it a dual-benefit ingredient for PCOS.

Zinc at a clinically meaningful dose addresses the androgen excess loop that hyperinsulinemia drives. Ones includes zinc at doses aligned with the therapeutic range used in PCOS trials (25–40 mg as zinc picolinate or bisglycinate), calibrated downward when dietary intake is assessed as adequate through the AI health history intake. Zinc is not a supplement to self-dose without knowing baseline serum zinc — at doses above 50 mg/day it begins to compete with copper absorption, which is why personalized dosing based on lab-informed status matters.

Vitamin D3 + K2 (MK-7) is included because the K2 component directs calcium away from arterial tissue and into bone — important for women with PCOS who have elevated cardiovascular risk — while D3 addresses the insulin sensitivity pathway directly. Ones doses Vitamin D3 based on reported serum 25(OH)D levels when available, or conservatively at 2,000–4,000 IU when levels are unknown, in line with Endocrine Society guidelines for deficiency correction.

The AI health practitioner at Ones analyzes lab values including fasting insulin, glucose, and reported nutrient markers, then builds a daily capsule formula around the specific deficiencies and metabolic patterns it identifies. That means the formula for a woman with a HOMA-IR of 3.8, low vitamin D, and low-normal zinc looks different from one built for a woman with a HOMA-IR of 1.8 but significant omega-3 deficiency — because those are fundamentally different metabolic states, even if both carry a PCOS diagnosis.

---

Key Takeaways

• A fasting insulin below 10 µIU/mL is optimal for women with PCOS; the standard lab reference range of up to 25 µIU/mL is not a PCOS-specific target and misses most early insulin resistance.
• HOMA-IR (fasting insulin × fasting glucose ÷ 405) is more clinically informative than fasting insulin alone — a HOMA-IR above 2.5 indicates significant insulin resistance even when individual values appear normal.
• Two-hour insulin during an OGTT catches postprandial hyperinsulinemia that fasting tests miss entirely; many women with PCOS have normal fasting insulin but spike dramatically after a glucose load.
• Insulin resistance in PCOS depletes magnesium, zinc, and vitamin D through specific mechanistic pathways — correcting those deficiencies improves both insulin sensitivity and androgen balance.
• The psychological burden of unrecognized or delayed-diagnosed insulin resistance is substantial; neurobiological effects of hyperinsulinemia directly impair mood, cognition, and energy independent of glucose levels.
• Supplementation should follow lab results, not a generic women's health formula — the right doses of magnesium glycinate, zinc, and vitamin D3+K2 are determined by your actual starting values, not a population average.

---

This article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your supplement regimen or interpreting lab results.